Registration Dossier

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Additional information

There is no need for in-vivo testing because all in-vitro endpoints were clearly negative, with and without metabolic activation.

Short description of key information:
Di-2-EHTDG was negative in all in-vitro assays (gene mutation in bacteria, cytogenicity, and gene mutation in mammalian cells).

Endpoint Conclusion: No adverse effect observed (negative)

Justification for classification or non-classification

Di-2 -EHTDG was negative in all in-vitro assays.